Statin prescribing among hypertensive patients in south-west Nigeria : findings and implications for the future

Tools

Akunne, Onyinye Onyeka and Godman, Brian and Adedapo, Aduragbenro Deborah and Truter, Ilse and Fadare, Joseph (2016) Statin prescribing among hypertensive patients in south-west Nigeria : findings and implications for the future. Journal of Comparative Effectiveness Research, 5 (3). pp. 281-288. ISSN 2042-6305 (https://doi.org/10.2217/CER.15.65)

[thumbnail of Akunne-etal-JCER-2015-Statin-prescribing-among-hypertensive-patients-in-south-west-Nigeria]
Preview
 Text. Filename: Akunne_etal_JCER_2015_Statin_prescribing_among_hypertensive_patients_in_south_west_Nigeria.pdf
Accepted Author Manuscript
Download (558kB)| Preview

Abstract

Statins reduce cardiovascular risk especially in patients with hypertension due to their concomitant blood pressure reducing effects. Prescribing generic statins minimizes cost and improves access. Our aim is to ascertain current prescribing of statins in Nigeria and potential savings from the increased use of generics. Prospective study involving hypertensive patients attending University College Hospital, Ibadan, Nigeria. 228 hypertensive patients received statins. Atorvastatin was the most prescribed statin, followed by simvastatin, rosuvastatin and finally fluvastatin. Prescribed doses were less than 1 defined daily dose in the majority, with high use of originators. Average monthly potential savings from increased prescribing of generics was US$2,635 for atorvastatin and US$10578 for rosuvastatin. A shift towards increased prescribing generics is recommended to minimize costs

CORE (COnnecting REpositories)